Zen Logsdon

Pages Tagged with "Zen Logsdon"

City of Hope’s Annual ‘Closing the Care Gap’ Event Underscores Commitment to Helping Eliminate Health Inequities
Music industry icons Lyor Cohen, 2023 City of Hope Spirit of Life® honoree, and Sylvia Rhone, 2019 Spirit of Life honoree, host leaders from across the music, film and entertainment...
Biomarkers may help detect prostate cancer risk in Black men
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments...
RESEARCH ALERT: City of Hope scientists unravel how TET2 gene deficiency fuels development of acute myeloid leukemia
Discovery could lead to targeted new treatments for aggressive cancer of the bone marrow CONTACT Zen Logsdon 626-409-9367 zlogsdon@coh.org  The return (i.e., homing) of leukemia stem cells (green) to the bone marrow microenvironment/niche (red) is substantially enhanced by low levels of TET2, at right, compared to the wild-type version of the gene. (Jianjun Chen Laboratory / City of Hope) FINDINGS Scientists at City of Hope, one of the largest...
City of Hope receives $32M grant to advance novel therapies
Researchers at City of Hope have been awarded $32.3 million from the California Institute for Regenerative Medicine (CIRM) to support three novel Phase 1 clinical trials evaluating innovative cell and...
City of Hope researchers identify biomarkers that may detect risk of advance prostate cancer in Black men
The identification of a cell metabolism process found in Black men with diabetes and prostate cancer could one day lead to the development of a disease prediction tool for this...
RESEARCH ALERT: City of Hope scientists uncover new active regions on cell surface receptor, expanding scope for drug targets to treat heart disease
Finding could lead to a new class of drugs to address cardiovascular side effects of some cancer therapies. CONTACT Zen Logsdon 626-409-9367 zlogsdon@coh.org Allosteric communication (shown as pipelines) spreads all around the protein structure, revealing multiple binding sites that can be harnessed for drug design. (Image credit: Wijnand J.C. van der Velden, Ph.D., co-first author of the study and a postdoctoral fellow in computational and quantitative medicine at Beckman Research Institute of City of Hope.) FINDINGS Scientists at City of Hope, one...
City of Hope researchers develop a CAR T cell therapy for advanced ovarian cancer
LOS ANGELES — There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. ...
City of Hope receives $32.3 million from the California Institute for Regenerative Medicine to advance innovative therapies for patients
The CIRM funds will support cell and gene therapy clinical trials for HIV, leukemia and a bone marrow disease CONTACT Zen Logsdon 626-409-9367 zlogsdon@coh.org  LOS ANGELES — Researchers at...
Targeted chemotherapy kills all tumor cells in preclinical research
Could a new molecule targeting a protein called PCNA help scientists develop a cancer-stopping pill? New preclinical research suggests it may be possible. Researchers aimed at a protein once thought to...
City of Hope-led panel of experts updates cancer and aging guidelines issued by the American Society of Clinical Oncology
A systematic evaluation of potential vulnerabilities in older adults called a geriatric assessment should be a requirement when treating people with cancer age 65 and over, a body of scientific...